XNAS · TMCI
+2.34% · +$0.1100 · Vol 344.8K
Market closed · last close 4:00 PM ET · price as of 19:15:24 ET
Treace Medical Concepts, Inc. Common Stock

Treace Medical Concepts, Inc. Common Stock

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$4.64
Card
Relationship Map

Follow $TMCI

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $TMCI by email

Veridion Score

BETALOW CONF · 4 of 6 factors measuredMethodology
Analyst data unavailable at compute time · Sentiment absence reason unknown
TMCI
Treace Medical Concepts, Inc. Common Stock
Sat Sep 19 · market closed · Markets closed · resumes Mon 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

45/ 100
Veridion Score
Middle range · LOW confidence · 4 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: LOW · 4 of 6 factors measured · Sat Sep 19 · market closed · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is TMCI moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading TMCI catalysts
About Treace Medical Concepts, Inc. Common Stock
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2021
Employees
450
Country
US

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$4.57
Day high
$4.68
Day low
$4.46
Previous close
$4.53
52W high
$6.95
-33.30% from high
52W low
$1.20
60% of range
Market cap
$292M
EPS
$-1.0600
Beta
0.64
Shares out
65M
Volume
344.8K
1.09× rel vol
Avg volume
317.5K
VWAP
$4.55
Price history computed in-house
1W
+2.79%
1M
+6.82%
3M
+15.61%
1Y
-32.72%
YTD
+89.22%
SMA 50 $4.49 · above
SMA 200 $2.99 · above
52W position 60%

TMCI overview

Loading financial statements
Loading TMCI Form 4 filings
Public disclosures

Congress activity in TMCI

No receipt-qualified Congressional disclosure is present for TMCI in the cached public ledger.

Federal contracts

TMCI contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for TMCI in this window.
Lobbying spend

TMCI lobbying filings, year to date.

Registered lobbying filings matched to Treace Medical Concepts, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for TMCI in this window.
Loading news for TMCI
Analyst ratings
Sovereign unlock shows live analyst consensus for TMCI.
Options
Sovereign unlock shows live options positioning for TMCI.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.